We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current 0R83 market cap is 671.78M. The company's latest EPS is BGN 0.0402 and P/E is 197.76.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BGN (BGN) | BGN (BGN) | BGN (BGN) | BGN (BGN) | BGN (BGN) | |
| Total Revenue | 34.72M | 40.39M | 42.56M | 43.87M | 48.59M |
| Operating Income | 2.95M | 589k | 2.56M | 3.05M | 4.01M |
| Net Income | 2.57M | 604k | 1.4M | 2.79M | 3.4M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BGN (BGN) | BGN (BGN) | BGN (BGN) | BGN (BGN) | BGN (BGN) | |
| Total Assets | 117.88M | 117.31M | 117.46M | 119.86M | 122.5M |
| Total Liabilities | 21.34M | 20.18M | 18.64M | 18.28M | 17.5M |
| Total Equity | 96.54M | 97.14M | 98.82M | 101.59M | 105M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BGN (BGN) | BGN (BGN) | BGN (BGN) | BGN (BGN) | BGN (BGN) | |
| Operating | 2.22M | 3.49M | 2.02M | 2.46M | 2.86M |
| Investing | -1.17M | -2.91M | -1.57M | -1.58M | -1.91M |
| Financing | -1.26M | -555k | -457k | -796k | -1.02M |
| Market Cap | 671.78M |
| Price to Earnings Ratio | 197.76 |
| Price to Sales Ratio | 13.83 |
| Price to Cash Ratio | 8.83k |
| Price to Book Ratio | 6.4 |
| Dividend Yield | - |
| Shares Outstanding | 84.5M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Tchaikapharma High Quality Medicine |
| Address |
no 1 g.m.dimitrov sofia 1172 |
| Website | https://www.tchaikapharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
